Research vs. Clinical Liquid Biopsy / Liquid Biopsy Market by Type of Analyte

DublinAnd January 14, 2022 /PRNewswire/ – “Global Liquid Biopsies Market 2021” report added ResearchAndMarkets.com Show.

While tissue biopsies and imaging techniques remain the current standards of care in the diagnosis of solid tumors, they do have risks, limitations, and limitations, some of which can be overcome by using liquid biopsy in clinical oncology, as an alternative or complementary method to the current standards of care technique.

This report contains up-to-date information and useful data points for business planning:

  • Research vs Clinical Liquid Biopsy
  • Liquid Biopsy Market by Region
  • Liquid Biopsy Market by Type of Analysis
  • CTC-Based Liquid Biopsy Market
  • ctDNA-Based Liquid Biopsy Market
  • Exosome-based liquid biopsy and EVs market
  • Multi-analytical liquid biopsy market
  • Other liquid biopsies market
  • Liquid Biopsy Market by Cancer Type (Breast, Lung, Colorectal, Ovarian, Prostate, Pan-Cancer, Other Cancers)
  • ctDNA-based liquid biopsy tests in development
  • Selected Market Available CTC-Based Liquid Biopsy Tests, 2021
  • Selected liquid biopsy tests evaluating multiple analyses, 2021

The liquid biopsy test has many potential applications in aspects of clinical oncology, including:

  • Detection and diagnosis / early examination
  • An alternative testing method when tissue biopsy is difficult/impossible, or when the primary site of metastatic disease is unknown
  • Treatment customization and monitoring – By molecular characterization of a patient’s disease, clinicians can determine the optimal course of treatment and monitor efficacy over time, as well as respond quickly to adjust treatment if treatment resistance appears
  • Disease monitoring – to monitor disease progression, tumor progression, residual disease, and early detection of disease recurrence
  • disease diagnosis

Main topics covered:

Chapter One: Executive Summary
Introduction
liquid biology techniques
Industry Structure
Liquid Dynamics Market Returns And Forecast

Chapter Two: Liquid Biotechnology
Introduction
Current major liquid biotechnologies

Chapter 3: Tumor DNA (CTDNA) Liquid Circulation
Introduction
Advantages and limitations of CTDNA in liquid biology
Current CTDNA-based liquid bioassays

  • Biocartes
  • Biocept
  • Biodesix
  • Cell Max’s life
  • Blood circulation
  • diacarta
  • Genetics
  • Foundation Medicine (Roche)
  • guard health
  • Enivata (Neogenomics)
  • LungLife AI
  • Countless genetics
  • NeoGenomics
  • Unko DNA
  • Personal genomic diagnostics
  • QIAGEN
  • Biological Sciences Decision
  • Roche Diagnostics
  • Sysmex-Inostics
  • time

CTDNA-based liquid bioassays in development

  • exact sciences
  • Freenom
  • Grill
  • neogenomics

Chapter 4: Cancer Cell Cycle (CTCS) Vital Fluid
Introduction
Challenges in developing CTC-based liquid bioassays
CTC Based Liquid Biological Tests

  • Adaptive biotechnologies
  • Biocept
  • Cell Max’s life
  • epic science
  • Globe
  • LungLife AI
  • Menarini-Silicon Biosystems
  • QIAGEN

CTC-based liquid bioassays in development

corner
epic science
liquid biotechnology United States of America

Chapter 5: Extracellular Vesicles and Other Liquid Biota
Introduction
Extracellular vesicle-based liquid bioassays/other analyses

  • Aspira Women’s Health (formerly Vermillion)
  • Biodesix
  • Exosome Diagnostics
  • holographic
  • MDxHealth

Extracellular vesicle/other assay-based liquid bioassays are under development

  • Blood circulation
  • OncoCyte
  • Biological Sciences Decision
  • VolitionRx

Chapter 6: Multiple Analytical Liquid Biological Tests
Liquid bioassays based on multiple analyses

  • Biocept
  • Biodesix
  • Foundation Medicine (Roche)
  • LungLife AI
  • NeoGenomics
  • Unko DNA

Multiple analysis-based liquid bioassays are under development

  • exact sciences
  • Freenom
  • Grill
  • LungLife AI

Chapter Seven: Liquid Biological Tests for Research Use Only
Introduction
Liquid bioassays for research use only

  • Agena Bioscience
  • corner
  • diacarta
  • Exosome Diagnostics
  • guard health
  • natira
  • QIAGEN

Chapter 8: Analysis of the liquid bio-industry
Competition levels
Competitive factors
Important market trends

  • personal medicine
  • Increasing life expectancy in the world
  • New liquid biopsy products
  • Increased access to genetic testing
  • organizational hurdles
  • Third party payer coverage
  • demonstrated clinical benefit
  • Incidence rates for certain types of cancer

No longer are competitors in the liquid bio-market

Chapter 9: Liquid Vital Market
Market Overview
market forecast

Chapter 10: Marketing Using Genetic Tumor Analysis

Tumor cell turnover
External vesicles and other analytes
Multiple Analytics

  • Market Overview
  • Applications
  • Technologies
  • samples
  • Income forecast

Chapter 11: Market by Application
Treatment and monitoring guidelines
Diagnosis / examination
disease diagnosis

  • Market Overview
  • Income forecast

Chapter 12: The Market by Type of Cancer
breast cancer
colorectal cancer
Lung Cancer
ovarian cancer
Prostate cancer
Other cancers: including diseases of the bladder, gastrointestinal tract, pancreas, kidneys, skin cancer, and hematological malignancies.

  • Market Overview
  • Income forecast

pan-cancer exams

  • Market Overview
  • Income forecast

Chapter Thirteen: Liquid Bio Company Profiles
Top ten companies in liquid biomaterials market

mentioned companies

  • Adaptive biotechnologies
  • Agena Bioscience, Inc.
  • angle, plc
  • Women’s Health Aspira
  • Biocartis Nv . Collection
  • Biocept, Inc.
  • Biodesix
  • Cellmax life
  • Blood circulation
  • Diacarta Corporation
  • epic science
  • Epigenomics AG
  • exact sciences
  • Exosome Diagnostics, Inc.
  • Foundation Medicine, Inc. (Roche)
  • Freenome, Inc.
  • Gilupi GmbH
  • Grail (Illumina)
  • Guardant Health, Inc.
  • holographic
  • Lunglife Ai (formerly Cynvenio Biosystems)
  • MDX Health
  • Menarini-Silicon Biosystems, Spa
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • Neogenomics Laboratories, Inc.
  • Oncocyte . company
  • Oncodena SA
  • Onciimmune
  • Personal genome diagnosis
  • Predicineq2 Solutions
  • Cell-free DNA techniques
  • CTC Technologies
  • Exosome and Mirna Technologies
  • Biological Sciences Decision (Agilent)
  • Roche Diagnostics
  • Stagezero . Life Sciences
  • Sysmex-Inostics, Inc.
  • time
  • VERASET
  • Volitionrx

For more information on this report, visit https://www.researchandmarkets.com/r/9iu3nb

Media contact:

Research and Markets
Laura Wood, director, mentor
[email protected]

For EST office hours, call +1-917-300-0470
For the US/Canada, call toll free +1-800-526-8630
For GMT office hours, call +353-1-416-8900

US Fax: 607-646-1907
Fax (outside the US): +353-1-481-1716

SOURCE Research & Markets

.

Leave a Comment